The EU funded SwitchMed program has since 2015, through UNIDO, implemented the MED TEST II project, to demonstrate a business case for resource efficient and cleaner production in Palestine. 10 companies from the food sector were selected to showcase how the UNIDO TEST concept can work in the food industry sector of Palestine.
Palestine Academy for Science and Technology in cooperation with the Palestinian Federation of Industries in Partnership with Ministry of Economy and Environmental Quality Authority were organized the ceremony on the dissemination of the results of the SwitchMed TEST II project on March 27, 2018 at Convention Palace Conferences in Bethlehem, this event is organized within the framework of SwitchMed Program on Sustainable Consumption and Production that is funded by the European Union.
In the dissemination event a major improvements in resource efficiency with significant saving impacts from 10 Palestine companies of the MED TEST II project were presented. The results, and recommendations from this SwitchMed component, will be shared to inform other Palestine companies on the opportunities of how to reduce their resource consumption and production costs.
Significant savings in energy, water, and raw materials, have been achieved for the partaking companies and this will enable them to operate with lower production cost – a vital condition for competing on the international markets.
Together with representatives from the Minister of National Economy, the Environment Quality Authority, and the EU Delegation to West Bank and Gaza Strip, UNIDO and Palestine Academy for Science and Technology (PALAST) were presented a national roadmap for resource efficiency, showing how the TEST methodology can be applied in other companies and sectors of Palestine.
This dissemination event provided an opportunity to represent the project outcomes, other outcomes achieved by SWITCH-MED in the region, and will be a platform where other industries, financial institutions, public agencies, and consulting firms be aware of the value of TEST-MED II outcomes and success stories.